Company Filing History:
1 out of 1 
1 out of 3 Years Active: 2015-2017
Title: Bruce W. Fenske: Innovator in Cyclosporine Analogue Molecules
Introduction
Bruce W. Fenske is a notable inventor based in Edmonton, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cyclosporine analogue molecules. With a total of 2 patents, his work has implications for immunosuppressive therapies.
Latest Patents
Fenske's latest patents focus on cyclosporine analogue molecules modified at amino acids 1 and 3. These analogs of cyclosporin-A include modifications of the substituents at these positions, which are designed to have an affinity for cyclophilin, including cyclophilin-A. Notably, these compounds exhibit reduced immunosuppressivity compared to cyclosporin-A and its analogs modified solely at position 1.
Career Highlights
Throughout his career, Bruce W. Fenske has worked with various companies, including Ciclofilin Pharmaceuticals Corp. and Contravir Pharmaceuticals, Inc. His expertise in the field has allowed him to contribute to innovative solutions in pharmaceutical development.
Collaborations
Fenske has collaborated with notable professionals in the industry, including Alexander Hegmans and Dan J. Trepanier. These collaborations have further enhanced his research and development efforts.
Conclusion
Bruce W. Fenske's contributions to the field of cyclosporine analogues highlight his innovative spirit and dedication to improving immunosuppressive therapies. His work continues to influence the pharmaceutical landscape.